Preliminary reports suggest conolidine might inhibit specific ion channels, minimizing neuronal excitability and restricting soreness indicators. This mechanism is especially suitable in neuropathic pain, where abnormal signaling causes persistent distress. Additionally, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integr